Pneumatosis intestinalis and pneumoperitoneum during treatment by paclitaxel.
Guiu
Séverine
S
Department of Oncology, Georges-François Leclerc Cancer Center, Dijon, France.
Ortega-Deballon
Pablo
P
Guiu
Boris
B
D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000009:adverse effects*; D011006:Pneumatosis Cystoides Intestinalis / Q000139:chemically induced*; D011027:Pneumoperitoneum / Q000139:chemically induced*
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel